一例患有高切氏症的罕见并发症--高切氏症和蛋白丢失性肠病

IF 1.8 4区 医学 Q3 GENETICS & HEREDITY Molecular Genetics and Metabolism Reports Pub Date : 2024-06-01 Epub Date: 2024-03-26 DOI:10.1016/j.ymgmr.2024.101075
Tianbo Zhang , Xialin Zhang , Ningning Zhang , Junrong Yan , Lina Wang , Weihong Yan , Zhuanzhuan Yu , Yonghong Zhang , Yanlong Duan , Ruijuan Zhang
{"title":"一例患有高切氏症的罕见并发症--高切氏症和蛋白丢失性肠病","authors":"Tianbo Zhang ,&nbsp;Xialin Zhang ,&nbsp;Ningning Zhang ,&nbsp;Junrong Yan ,&nbsp;Lina Wang ,&nbsp;Weihong Yan ,&nbsp;Zhuanzhuan Yu ,&nbsp;Yonghong Zhang ,&nbsp;Yanlong Duan ,&nbsp;Ruijuan Zhang","doi":"10.1016/j.ymgmr.2024.101075","DOIUrl":null,"url":null,"abstract":"<div><p>This case report describes a patient initially diagnosed with Gaucher disease (GD) with type I with homozygous mutation c.1448T &gt; C p. (Leu483Pro) at age of 2, presenting with hepatosplenomegaly and cytopenia. Imiglucerase replacement therapy was initiated. At age 17, bilateral hearing loss developed, with subsequent Cranial MRI revealing thalamic damage, leading to a reclassification as type 3 GD. By age of 20, the patient presented with a range of symptoms, including abdominal pain, diarrhea, hypoproteinemia, multiple lymphadenopathy, edema, and Gaucher cell infiltration in the lymph nodes. Comprehensive diagnosis identifies Gaucher tumor and protein-losing enteropathy. Imiglucerase therapy at 90‐120 U/kg every 2 weeks significantly improved clinical symptoms, emphasizing the importance of tailored interventions for managing GD manifestations.</p></div>","PeriodicalId":18814,"journal":{"name":"Molecular Genetics and Metabolism Reports","volume":"39 ","pages":"Article 101075"},"PeriodicalIF":1.8000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2214426924000284/pdfft?md5=6a9ca47733793eff8dcf71168e66ba93&pid=1-s2.0-S2214426924000284-main.pdf","citationCount":"0","resultStr":"{\"title\":\"A case of gaucher disease with a rare complication of gaucheroma and protein-losing enteropathy\",\"authors\":\"Tianbo Zhang ,&nbsp;Xialin Zhang ,&nbsp;Ningning Zhang ,&nbsp;Junrong Yan ,&nbsp;Lina Wang ,&nbsp;Weihong Yan ,&nbsp;Zhuanzhuan Yu ,&nbsp;Yonghong Zhang ,&nbsp;Yanlong Duan ,&nbsp;Ruijuan Zhang\",\"doi\":\"10.1016/j.ymgmr.2024.101075\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>This case report describes a patient initially diagnosed with Gaucher disease (GD) with type I with homozygous mutation c.1448T &gt; C p. (Leu483Pro) at age of 2, presenting with hepatosplenomegaly and cytopenia. Imiglucerase replacement therapy was initiated. At age 17, bilateral hearing loss developed, with subsequent Cranial MRI revealing thalamic damage, leading to a reclassification as type 3 GD. By age of 20, the patient presented with a range of symptoms, including abdominal pain, diarrhea, hypoproteinemia, multiple lymphadenopathy, edema, and Gaucher cell infiltration in the lymph nodes. Comprehensive diagnosis identifies Gaucher tumor and protein-losing enteropathy. Imiglucerase therapy at 90‐120 U/kg every 2 weeks significantly improved clinical symptoms, emphasizing the importance of tailored interventions for managing GD manifestations.</p></div>\",\"PeriodicalId\":18814,\"journal\":{\"name\":\"Molecular Genetics and Metabolism Reports\",\"volume\":\"39 \",\"pages\":\"Article 101075\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2214426924000284/pdfft?md5=6a9ca47733793eff8dcf71168e66ba93&pid=1-s2.0-S2214426924000284-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Genetics and Metabolism Reports\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2214426924000284\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/26 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"GENETICS & HEREDITY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Genetics and Metabolism Reports","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214426924000284","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/26 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

摘要

本病例报告描述了一名两岁时被初步诊断为 I 型戈谢病(GD)的患者,其基因突变为 c.1448T > C p. (Leu483Pro),表现为肝脾肿大和全血细胞减少。开始接受替代治疗。17 岁时,出现双侧听力损失,随后的头颅磁共振成像显示丘脑受损,从而被重新归类为 3 型 GD。20 岁时,患者出现一系列症状,包括腹痛、腹泻、低蛋白血症、多发性淋巴结病、水肿和淋巴结戈谢细胞浸润。综合诊断确定为戈谢瘤和蛋白丢失性肠病。每 2 周进行 90-120 U/kg的治疗可明显改善临床症状,这强调了有针对性的干预对控制戈谢病表现的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A case of gaucher disease with a rare complication of gaucheroma and protein-losing enteropathy

This case report describes a patient initially diagnosed with Gaucher disease (GD) with type I with homozygous mutation c.1448T > C p. (Leu483Pro) at age of 2, presenting with hepatosplenomegaly and cytopenia. Imiglucerase replacement therapy was initiated. At age 17, bilateral hearing loss developed, with subsequent Cranial MRI revealing thalamic damage, leading to a reclassification as type 3 GD. By age of 20, the patient presented with a range of symptoms, including abdominal pain, diarrhea, hypoproteinemia, multiple lymphadenopathy, edema, and Gaucher cell infiltration in the lymph nodes. Comprehensive diagnosis identifies Gaucher tumor and protein-losing enteropathy. Imiglucerase therapy at 90‐120 U/kg every 2 weeks significantly improved clinical symptoms, emphasizing the importance of tailored interventions for managing GD manifestations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular Genetics and Metabolism Reports
Molecular Genetics and Metabolism Reports Biochemistry, Genetics and Molecular Biology-Endocrinology
CiteScore
4.00
自引率
5.30%
发文量
105
审稿时长
33 days
期刊介绍: Molecular Genetics and Metabolism Reports is an open access journal that publishes molecular and metabolic reports describing investigations that use the tools of biochemistry and molecular biology for studies of normal and diseased states. In addition to original research articles, sequence reports, brief communication reports and letters to the editor are considered.
期刊最新文献
Examining the role of social workers within clinical metabolic genetics care Newborn screening for Fabry disease in Japan: an additional 3-year report Pathogenic variants in COL4A3, COL4A4, JAG1, and NPHS2 genes in focal segmental glomerulosclerosis: Insights from targeted gene panel sequencing Acid sphingomyelinase deficiency: Phenotypic, biochemical, and molecular heterogeneity in a series of 47 Iraqi patients from a single center OCA2 common variant NM_000275.3:c.574-19A>G affects splicing and is pathogenic.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1